Drug therapy: Preclinical oncology-reporting transparency needed Journal Article

  

Authors:	Gardner, E. E.; Rudin, C. M.
Article Title:	Drug therapy: Preclinical oncology-reporting transparency needed
Keywords:	sunitinib; dose response; drug efficacy; monotherapy; nonhuman; risk benefit analysis; note; outcome assessment; methodology; gastrointestinal stromal tumor; tumor volume; practice guideline; oncology; publication; kidney carcinoma; cancer inhibition; peer review; drug response; medical practice; construct validity; predictive value; transgenic organism; external validity; internal validity; meta analysis (topic); oncologist; pancreatic neuroendocrine tumor; human; priority journal
Journal Title:	Nature Reviews Clinical Oncology
Volume:	13
Issue:	1
ISSN:	1759-4774
Publisher:	Nature Publishing Group
Date Published:	2016-01-01
Start Page:	8
End Page:	9
Language:	English
DOI:	10.1038/nrclinonc.2015.216
PROVIDER:	scopus
PUBMED:	26667971
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-84951908866&partnerID=40&md5=39cc78aa4ecdd25f8ea3e5279f888cf7
Notes:	Note -- Export Date: 3 February 2016 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/87864